<DOC>
	<DOCNO>NCT00327587</DOCNO>
	<brief_summary>The purpose study determine safety efficacy various combination valsartan , HCTZ , amlodipine patient moderate severe hypertension .</brief_summary>
	<brief_title>8-week Study Evaluate Safety Efficacy Various Combinations Valsartan , HCTZ , Amlodipine Patients With Moderate Severe Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Hydrochlorothiazide</mesh_term>
	<mesh_term>Valsartan</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<criteria>Diagnosis moderate severe hypertension ( MSDBP ≥ 100 mmHg &lt; 120 mmHg , MSSBP ≥ 145 mmHg &lt; 200 mmHg ) . Patients two antihypertensive drug MSSBP ≥ 180 mmHg and/or MSDBP ≥ 110 mmHg Visit 1 . Patients three antihypertensive drug MSDBP ≥ 90 mmHg &lt; 110 mmHg , and/or MSSBP ≥ 140 mmHg &lt; 180 mmHg Visit 1 . Patients four antihypertensive drug Visit 1 . Arm circumference &gt; 42 cm patient participate ABPM . Other protocoldefined exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>November 2011</verification_date>
	<keyword>hypertension</keyword>
	<keyword>valsartan</keyword>
	<keyword>amlodipine</keyword>
	<keyword>HCTZ</keyword>
</DOC>